Table 2.
Effect of AEHE on serum glucose levels in rats during the experiment days
| NM | NM + AEHE | DM | DM + LAEHE | DM + HAEHE | DM + Gli | |
|---|---|---|---|---|---|---|
| Day 0 |
105.6 ± 7.8 |
109.3 ± 8.6 |
278.9 ± 11.2a |
286.3 ± 9.4a |
291.0 ± 11.9a |
289.1 ± 10.3a |
| Day 14 |
106.1 ± 8.1 |
103.4 ± 7.2 |
289.7 ± 10.4a |
226.5 ± 8.7a,b,c |
199.6 ± 12.5a,b,c |
202.3 ± 8.5a,b,c |
| Day 28 | 107.3 ± 7.0 | 98.3 ± 9.9 | 296.1 ± 8.8a | 163.2 ± 9.6a,b,c | 135.4 ± 10.9a,b,c | 129.3 ± 8.3a,b,c |
Values are expressed as mean ± SD in each group. NM group: normal control rats treated with vehicle alone; NM + AEHE group: normal control rats treated with AEHE (100 mg/kg b.w.); DM group: diabetic control rats treated with vehicle alone; DM + LAEHE group: diabetic rats were given AEHE (100 mg/kg b.w.); DM + HAEHE group: diabetic rats were given AEHE (200 mg/kg b.w.); DM + Gli group: diabetic rats were given glibenclamide (30 mg/kg b.w.). aindicates statistical significance of P < 0.05 compared to the NM group; bindicates statistical significance of P < 0.05 compared to the DM group. cindicates statistical significance of P < 0.05 compared to the same group at day 0.